Close
  Indian J Med Microbiol
 

Figure 3: Log10 cfu of Salmonella Typhimurium in (A) livers, (B) spleens and (C) small intestines of infected mice after 48 h of therapy with cryptdin-2 (cry) and ceftriaxone (CRO) separately and in combination. Values are expressed as mean ± standard deviation of three independent experiments. *P<0.05 compared to untreated mice (infected-control); #P<0.05 compard to mice treated with cryptdin-2 (5 μg/mouse); †P <0.05 compared to mice treated with CRO (25 mg/kg body weight); ‡P<0.05 compared to mice treated with CRO (50 mg/kg body weight). Uninfected control group comprising six mice was also used in the study (not shown as no bacterial load was recovered from this group).

Figure 3: Log<sub>10</sub> cfu of <i>Salmonella Typhimurium</i> in (A) livers, (B) spleens and (C) small intestines of infected mice after 48 h of therapy with cryptdin-2 (cry) and ceftriaxone (CRO) separately and in combination. Values are expressed as mean ± standard deviation of three independent experiments. *<i>P</i><0.05 compared to untreated mice (infected-control); #<i>P</i><0.05 compard to mice treated with cryptdin-2 (5 μg/mouse); †<i>P</i> <0.05 compared to mice treated with CRO (25 mg/kg body weight); ‡<i>P</i><0.05 compared to mice treated with CRO (50 mg/kg body weight). Uninfected control group comprising six mice was also used in the study (not shown as no bacterial load was recovered from this group).